A Better Everyday Life Among Persons With Chronic Conditions
NCT ID: NCT04295837
Last Updated: 2022-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2019-12-09
2021-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and Methods: The design involves a randomized controlled trial, initiated with an internal pilot. The study will include eighty (n=80) home dwelling persons living with chronic conditions, experiencing problems performing ADL. Participants are randomized to either intervention (ABLE) or control (usual care).
Co-primary outcomes are self-reported ADL ability measured using ADL-Questionnaire (ADL-Q) and observed ADL motor ability measured using Assessment of Motor and Process Skills (AMPS). Secondary outcomes are perceived satisfaction with ADL task performance measured using ADL-Q; observed ADL process ability measured using AMPS; and Goal Attainment measured using Goal-Attainment-Scaling (GAS). Data is collected at baseline, post intervention and six months after baseline. Process evaluation data are collected using registration forms and semi-structured qualitative interviews.
The economic evaluation will be performed from a health care sector perspective with 6 months follow-up. Costs will be estimated based on micro costing and national registries. Effects will be Quality Adjusted Life Years and changes in AMPS ADL ability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Overall Functioning in Patients With Complex Health Issues
NCT06410014
Rehabilitation and Return to Everyday Life for Patients With Long COVID
NCT06544382
Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia
NCT06291909
Living With Multimorbidity: CO-ORDINATE Program
NCT05985044
Self-management and HeAlth Promotion in Early-stage Dementia With E-learning for Carers
NCT04286139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABLE - A Better everday LifE
A home-based occupational therapy intervention addressing ADL task performance issues among persons living with chronic conditions. The ABLE intervention is occupation-focused and -based, and follows a structured process of assessment, goalsetting, intervention and evaluation.
ABLE
Home-based occupational therapy compensatory programme addressing activities of daily living
Usual care
Community-based occupational therapy addressing ADL task performance issues among persons living with chronic conditions
Usual Care
Standard occupational therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABLE
Home-based occupational therapy compensatory programme addressing activities of daily living
Usual Care
Standard occupational therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Perceive problems performing ADL tasks
* ≥ 18 years of age
* Lives in own home
* Motivated and ready for making changes in ADL performance
* Motivated and ready to participate in program
* Communicates independently and relevant
* Able to understand and relevantly answer a questionnaire
Exclusion Criteria
* Known substance abuse
* Mental illness, and/or other acute illness effecting ADL task performance
* Communication barriers (e.g. severe cognitive deficits; and barriers that prevents receiving information on study)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern Denmark
OTHER
VIA University College
OTHER
Parker Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Ejlersen Wæhrens
Senior researcher, associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva E Wæhrens, PhD
Role: PRINCIPAL_INVESTIGATOR
The Parker Research Institute, Bispebjerg and Frederiksberg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Parker Research Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg
Frederiksberg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hagelskjaer V, Nielsen KT, von Bulow C, Oestergaard LG, Graff M, Waehrens EE. Evaluating a complex intervention addressing ability to perform activities of daily living among persons with chronic conditions: study protocol for a randomised controlled trial (ABLE). BMJ Open. 2021 Nov 26;11(11):e051722. doi: 10.1136/bmjopen-2021-051722.
Hagelskjaer V, Nielsen KT, von Bulow C, Graff M, Waehrens EE. Occupational therapy addressing the ability to perform activities of daily living among persons living with chronic conditions: a randomised controlled pilot study of ABLE 2.0. Pilot Feasibility Stud. 2021 Jun 11;7(1):122. doi: 10.1186/s40814-021-00861-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.